Costica Aloman to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Costica Aloman has written about Carcinoma, Hepatocellular.
Connection Strength
1.052
-
Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinoma. Hepatol Commun. 2022 11; 6(11):3247-3259.
Score: 0.815
-
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study. Clin Gastroenterol Hepatol. 2021 Jul; 19(7):1469-1479.e19.
Score: 0.178
-
Antibody-directed therapy for human hepatocellular carcinoma. Gastroenterology. 2004 Nov; 127(5 Suppl 1):S225-31.
Score: 0.059